ProCAncer-I at the RSNA 2022 in Chicago

Published on: December 1, 2022
Categories: News

Our Scientific Manager, Dr Nickolas Papanikolaou was at the 108th Scientific Assembly and Annual meeting (Chicago 27-30/11/2022).

The panel discussion included Dr Mona Flores, Global Head of Medical AI at NVIDIA, and Dr Nikos Papanikolaou, Computational Clinical Imaging Group Lead at the Champalimaud Foundation & Machine Learning Imaging Lead at the Royal Marsden Hospital, London. It was chaired by Dr Rowland Illing, Director & Chief Medical Officer, International Public Sector Health at AWS & Hon Assoc Prof at UCL, London. The panel entitled “Radiology AI Innovation: Academics vs Industry” described how researchers and radiologists can best leverage tech industry partners to accelerate their research, providing real-world examples of how this has taken place internationally. They described to a large audience of stakeholders the next generation of imaging AI capabilities that will be coming to market, and how the audience will be able to leverage these in the future.

Photo by Razvan Ionasec                   


ProCAncer-I: Session on RSNA 2022 by Quibim

Mark Wittenberg also presented a session at the RSNA 2022 in Chicago called “Advancements in Prostate MRI: Quibim” in which he communicated about ProCΑncer-I project






Stay in touch!